Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1975 Apr;2(2):99–105. doi: 10.1111/j.1365-2125.1975.tb01564.x

Beta-adrenoceptors in the human dorsal hand vein, and the effects of propranolol and practolol on venous sensitivity to noradrenaline.

C B White, B P Udwadia
PMCID: PMC1402521  PMID: 186090

Abstract

1 Infusion of isoprenaline into dorsal hand veins preconstricted with noradrenaline produced vasodilatation in four subjects out of five which was reversed by addition of propranolol. It is confirmed that beta-adrenoceptors are present in the hand veins of most subjects. 2 Addition of either propranolol or practolol to infusions of vasoconstrictor doses of noradrenaline potentiated the vasoconstriction in the hand vein. 3 After systemic administration of propranolol (0.3 mg/kg) or of practolol (1.0 mg/kg) intravenously, the sensitivity of the hand vein to the vasoconstrictor activity of noradrenaline was increased by 7.5 times and 2.9 times respectively. Significant reductions in hand skin temperature and resting pulse rate occurred after propranolol only. 4 It is suggested that this may be a useful method for the quantitative estimation of peripheral vascular beta-adrenoceptor blocking activity in man. At the doses used, significant beta-adrenoceptor blockade appears to occur at this site with practolol as well as propranolol.

Full text

PDF
103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aminu J. M., Vere D. W. The effects of oral propranolol on the distensibility of resting superficial veins in man. Clin Sci. 1972 Jan;42(1):3P–3P. doi: 10.1042/cs042003p. [DOI] [PubMed] [Google Scholar]
  2. Bevan J. A., Su C. Sympathetic mechanisms in blood vessels: nerve and muscle relationships. Annu Rev Pharmacol. 1973;13:269–285. doi: 10.1146/annurev.pa.13.040173.001413. [DOI] [PubMed] [Google Scholar]
  3. Briant R. H., Dollery C. T., Fenyvesi T., George C. F. Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol. 1973 Sep;49(1):106–114. doi: 10.1111/j.1476-5381.1973.tb08272.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brick I., Hutchison K. J., McDevitt D. G., Roddie I. C., Shanks R. G. Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. Br J Pharmacol. 1968 Sep;34(1):127–140. doi: 10.1111/j.1476-5381.1968.tb07956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burks T. F., Cooper T. Enhancement of peripheral alpha-receptor stimulation by blockade of "silent" beta receptors. Circ Res. 1967 Nov;21(5):703–715. doi: 10.1161/01.res.21.5.703. [DOI] [PubMed] [Google Scholar]
  6. Collier J. G., Nachev C., Robinson B. F. Effect of catecholamines and other vasoactive substances on superficial hand veins in man. Clin Sci. 1972 Sep;43(3):455–467. doi: 10.1042/cs0430455. [DOI] [PubMed] [Google Scholar]
  7. Day M. D., Roach A. G. Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats. Br J Pharmacol. 1974 Jul;51(3):325–333. doi: 10.1111/j.1476-5381.1974.tb10666.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. De La Lande I. S., Waterson J. G. Site of action of cocaine on the perfused artery. Nature. 1967 Apr 15;214(5085):313–314. doi: 10.1038/214313a0. [DOI] [PubMed] [Google Scholar]
  9. Dustan H. P., Tarazi R. C., Bravo E. L. Dependence of arterial pressure on intravascular volume in treated hypertensive patients. N Engl J Med. 1972 Apr 20;286(16):861–866. doi: 10.1056/NEJM197204202861603. [DOI] [PubMed] [Google Scholar]
  10. Foo J. W., Jowett A., Stafford A. The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart. Br J Pharmacol. 1968 Sep;34(1):141–147. doi: 10.1111/j.1476-5381.1968.tb07957.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Furchgott R. F. The pharmacological differentiation of adrenergic receptors. Ann N Y Acad Sci. 1967 Feb 10;139(3):553–570. doi: 10.1111/j.1749-6632.1967.tb41229.x. [DOI] [PubMed] [Google Scholar]
  12. Greenblatt D. J., Koch-Weser J. Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program. Drugs. 1974;7(1):118–129. doi: 10.2165/00003495-197407010-00008. [DOI] [PubMed] [Google Scholar]
  13. Harrison J., Turner P. Comparison of propranolol and I.C.I. 50,172 on isoprenaline-induced increase in skin temperature in man. Br J Pharmacol. 1969 May;36(1):177P–178P. [PMC free article] [PubMed] [Google Scholar]
  14. Julius S., Pascual A. V., Abbrecht P. H., London R. Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med. 1972 Jul;140(3):982–985. doi: 10.3181/00379727-140-36594. [DOI] [PubMed] [Google Scholar]
  15. Leon D. F., Thompson M. E., Shaver J. A., McDonald R. H., Jr Hemodynamic effects of practolol at rest and during exercise. Circulation. 1972 Jan;45(1):46–54. doi: 10.1161/01.cir.45.1.46. [DOI] [PubMed] [Google Scholar]
  16. Lewis C. M., Brink A. J. Beta adrenergic blockade. Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease. Am J Cardiol. 1968 Jun;21(6):846–859. doi: 10.1016/0002-9149(68)90303-2. [DOI] [PubMed] [Google Scholar]
  17. Mazurkiewicz-Kwilecki I. M. Antagonistic effects of beta-adreneric blocking agents on responses to adrenaline in vascular smooth muscle. Arch Int Pharmacodyn Ther. 1968 Jul;174(1):199–209. [PubMed] [Google Scholar]
  18. Nachev C., Collier J., Robinson B. Simplified method for measuring compliance of superficial veins. Cardiovasc Res. 1971 Jan;5(1):147–156. doi: 10.1093/cvr/5.1.147. [DOI] [PubMed] [Google Scholar]
  19. Price H. L., Cooperman L. H., Warden J. C. Control of the splanchnic circulation in man. Role of beta-adrenergic receptors. Circ Res. 1967 Sep;21(3):333–340. doi: 10.1161/01.res.21.3.333. [DOI] [PubMed] [Google Scholar]
  20. Prichard B. N., Ross E. J. Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma. Am J Cardiol. 1966 Sep;18(3):394–398. doi: 10.1016/0002-9149(66)90061-0. [DOI] [PubMed] [Google Scholar]
  21. Ross G., Jorgensen C. R. Effects of a cardio-selective beta-adrenergic blocking agent on the heart and coronary circulation. Cardiovasc Res. 1970 Apr;4(2):148–153. doi: 10.1093/cvr/4.2.148. [DOI] [PubMed] [Google Scholar]
  22. Webb-Peploe M. M., Shepherd J. T. Beta-receptor mechanisms in the superficial limb veins of the dog. J Clin Invest. 1969 Jul;48(7):1328–1335. doi: 10.1172/JCI106099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wolfson S., Gorlin R. Cardiovascular pharmacology of propranolol in man. Circulation. 1969 Oct;40(4):501–511. doi: 10.1161/01.cir.40.4.501. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES